BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

313 related articles for article (PubMed ID: 9808161)

  • 1. Sex- and strain-specific expression of cytochrome P450s in ochratoxin A-induced genotoxicity and carcinogenicity in rats.
    Pfohl-Leszkowicz A; Pinelli E; Bartsch H; Mohr U; Castegnaro M
    Mol Carcinog; 1998 Oct; 23(2):76-85. PubMed ID: 9808161
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Sex- and strain-specific induction of renal tumors by ochratoxin A in rats correlates with DNA adduction.
    Castegnaro M; Mohr U; Pfohl-Leszkowicz A; Estève J; Steinmann J; Tillmann T; Michelon J; Bartsch H
    Int J Cancer; 1998 Jul; 77(1):70-5. PubMed ID: 9639396
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Ochratoxin A, ubiquitous mycotoxin contaminating human food].
    Pfohl-Leszkowicz A
    C R Seances Soc Biol Fil; 1994; 188(4):335-53. PubMed ID: 7736257
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Interstrain comparison of hepatic and renal microsomal carcinogen metabolism and liver S9-mediated mutagenicity in DA and Lewis rats phenotyped as poor and extensive metabolizers of debrisoquine.
    Hietanen E; Malaveille C; Camus AM; Béréziat JC; Brun G; Castegnaro M; Michelon J; Idle JR; Bartsch H
    Drug Metab Dispos; 1986; 14(1):118-26. PubMed ID: 2868854
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ochratoxin A: An overview on toxicity and carcinogenicity in animals and humans.
    Pfohl-Leszkowicz A; Manderville RA
    Mol Nutr Food Res; 2007 Jan; 51(1):61-99. PubMed ID: 17195275
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evidence for covalent DNA adduction by ochratoxin A following chronic exposure to rat and subacute exposure to pig.
    Faucet V; Pfohl-Leszkowicz A; Dai J; Castegnaro M; Manderville RA
    Chem Res Toxicol; 2004 Sep; 17(9):1289-96. PubMed ID: 15377164
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ochratoxin a causes DNA damage and cytogenetic effects but no DNA adducts in rats.
    Mally A; Pepe G; Ravoori S; Fiore M; Gupta RC; Dekant W; Mosesso P
    Chem Res Toxicol; 2005 Aug; 18(8):1253-61. PubMed ID: 16097798
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Further arguments in favour of direct covalent binding of Ochratoxin A (OTA) after metabolic biotransformation.
    Pfohl-Leszkowicz A; Castegnaro M
    Food Addit Contam; 2005; 22 Suppl 1():75-87. PubMed ID: 16332625
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ochratoxin A induces oxidative DNA damage in liver and kidney after oral dosing to rats.
    Kamp HG; Eisenbrand G; Janzowski C; Kiossev J; Latendresse JR; Schlatter J; Turesky RJ
    Mol Nutr Food Res; 2005 Dec; 49(12):1160-7. PubMed ID: 16302199
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Metabolism of ochratoxin A: absence of formation of genotoxic derivatives by human and rat enzymes.
    Gautier J; Richoz J; Welti DH; Markovic J; Gremaud E; Guengerich FP; Turesky RJ
    Chem Res Toxicol; 2001 Jan; 14(1):34-45. PubMed ID: 11170506
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Oxidative DNA damage induced by Ochratoxin A in the HK-2 human kidney cell line: evidence of the relationship with cytotoxicity.
    Arbillaga L; Azqueta A; Ezpeleta O; López de Cerain A
    Mutagenesis; 2007 Jan; 22(1):35-42. PubMed ID: 17130176
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evidence of a new dechlorinated ochratoxin A derivative formed in opossum kidney cell cultures after pretreatment by modulators of glutathione pathways: correlation with DNA-adduct formation.
    Faucet-Marquis V; Pont F; Størmer FC; Rizk T; Castegnaro M; Pfohl-Leszkowicz A
    Mol Nutr Food Res; 2006 May; 50(6):530-42. PubMed ID: 16671059
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Characterization of the cytochrome P450 isozyme that metabolizes ochratoxin A, using metabolic inducers, inhibitors and antibodies.
    Hietanen E; Bartsch H; Béréziat JC; Castegnaro M; Michelon J
    IARC Sci Publ; 1991; (115):297-304. PubMed ID: 1820345
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Strain-specific mammary proliferative lesion development following lifetime oral administration of ochratoxin A in DA and Lewis rats.
    Son WC; Kamino K; Lee YS; Kang KS
    Int J Cancer; 2003 Jun; 105(3):305-11. PubMed ID: 12704662
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ochratoxin A: lack of formation of covalent DNA adducts.
    Mally A; Zepnik H; Wanek P; Eder E; Dingley K; Ihmels H; Völkel W; Dekant W
    Chem Res Toxicol; 2004 Feb; 17(2):234-42. PubMed ID: 14967011
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ochratoxin A: induction of (oxidative) DNA damage, cytotoxicity and apoptosis in mammalian cell lines and primary cells.
    Kamp HG; Eisenbrand G; Schlatter J; Würth K; Janzowski C
    Toxicology; 2005 Jan; 206(3):413-25. PubMed ID: 15588931
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Ochratoxin A genotoxicity, relation to renal tumors].
    Maaroufi K; Pfohl-Leszkowicz A; Achour A; el May M; Grosse Y; Hammami M; Ellouz F; Creppy EE; Bacha H
    Arch Inst Pasteur Tunis; 1994; 71(1-2):21-31. PubMed ID: 7661650
    [TBL] [Abstract][Full Text] [Related]  

  • 18. DNA adduct formation by ochratoxin A: review of the available evidence.
    Mally A; Dekant W
    Food Addit Contam; 2005; 22 Suppl 1():65-74. PubMed ID: 16332624
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ochratoxin A as a potential etiologic factor in endemic nephropathy: lessons from toxicity studies in rats.
    Mally A; Hard GC; Dekant W
    Food Chem Toxicol; 2007 Nov; 45(11):2254-60. PubMed ID: 17629386
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A toxicogenomics approach to identify new plausible epigenetic mechanisms of ochratoxin a carcinogenicity in rat.
    Marin-Kuan M; Nestler S; Verguet C; Bezençon C; Piguet D; Mansourian R; Holzwarth J; Grigorov M; Delatour T; Mantle P; Cavin C; Schilter B
    Toxicol Sci; 2006 Jan; 89(1):120-34. PubMed ID: 16251485
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.